Why Is the North America Molecular Diagnostics Market Expected to Be Worth $18.13 Billion by 2030?


Posted October 15, 2024 by Pratiksha

The Molecular Diagnostics Market in North America is expected to grow at a 5.3% CAGR from 2023, reaching $18.13 billion by 2030. Delve into the trends that are transforming this essential healthcare sector.
 
A new report from Meticulous Research®, titled ‘North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User—Forecast to 2030,’ outlines the rapid growth expected in the molecular diagnostics market. The market is projected to reach $18.13 billion by 2030, with a CAGR of 5.3% from 2024 to 2030.

Request For Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5642?

Growth Drivers
The aging population in North America, increased prevalence of both communicable and non-communicable diseases, technological advancements, and rising healthcare spending are key drivers propelling the growth of the molecular diagnostics market in this region. These factors are expected to create sustained demand for diagnostic products and services.

Challenges to Market Growth
The market is not without its challenges. Unfavorable regulatory environments and the high cost of molecular diagnostic tests are major obstacles that could slow down the market's progress. These issues highlight the need for cost-effective and streamlined regulatory processes.

Opportunities for Expansion
Opportunities in the molecular diagnostics market are abundant, particularly with the rise of companion diagnostics and direct-to-consumer genetic testing. These areas represent significant growth potential for companies looking to capitalize on evolving consumer preferences and the shift towards personalized healthcare.

AI and Machine Learning Trends
A significant trend influencing the market is the **growing use of AI
and machine learning** technologies in molecular diagnostics. The integration of these technologies is expected to enhance diagnostic accuracy, improve efficiency, and facilitate the analysis of large datasets, positioning companies for growth in a competitive landscape.

Leading Companies
The North America molecular diagnostics market features key players such as Hologic, Inc., Danaher Corporation, BioMérieux S.A., Abbott Laboratories, and Thermo Fisher Scientific Inc. These companies are at the forefront of innovation, continually expanding their product portfolios to meet market demands.

Market Segmentation Analysis
The North America molecular diagnostics market is segmented by various criteria, including Product & Service, Test Type, Technology, Application, and End User.
• Kits & Reagents are expected to lead the product segment due to the increasing development of diagnostic tests for infectious diseases.
• The sequencing segment is anticipated to experience rapid growth, driven by advancements in technology that make it more accessible and cost-effective.
• The laboratory tests segment is expected to hold a significant share of the market due to their accuracy and reliability.
• Oncology is projected to witness the highest growth among applications, as molecular diagnostics play a crucial role in the management of cancer.
• In terms of end users, hospitals & clinics are likely to dominate the market, reflecting their role as primary providers of diagnostic services.

Regional Market Insights
The report emphasizes the U.S. as the leading market within North America. Factors such as the aging population and the increasing prevalence of chronic diseases are expected to drive significant demand for molecular diagnostics. The focus on improving healthcare outcomes will further stimulate market growth in this region.

Buy Now: https://www.meticulousresearch.com/Checkout/62458641?

About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to detail. With meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Meticulous Research
Phone 07447780008
Business Address Office No-202, 203,204,205,206; 2nd Floor, Pushpak Business Hub, Pune, Wakad, Pimpri-Chinchwad, Maharashtra 411057
Country India
Categories Health , Medical , Research
Last Updated October 15, 2024